22 May 2013
Keywords: everolimus, trial, halted, after, early, pfs, gains
Article | 10 March 2008
Swiss drug major Novartis says that a late-stage Phase III trial of its kidney cancer drug everolimus has been stopped ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 March 2008
3 March 2008
21 May 2013
© 2013 thepharmaletter.com